BioSpace News Archive

Business

PureTech Health: Notice of Half-Yearly Results

PureTech Health plc plans to announce its half-yearly results for the six months ended June 30, 2023, on Tuesday, August 29, 2023.

August 22, 2023
·
3 min read
Drug Development

Bredis Healthcare Awarded South Korean Government Grant for Advancing Early Diagnosis of Alzheimer’s Disease

Bredis Healthcare, Inc. announced that they have been selected by South Korea’s Ministry of SMEs and Startups to receive its Deep Tech TIPS grant.

August 22, 2023
·
4 min read
Biotech Bay

Mainz Biomed Announces Live Launch of ColoAlert® with testDNA Laboratory in Poland

Mainz Biomed NV, a molecular genetics diagnostic company specializing in the early detection of cancer, announces the commercial launch of ColoAlert® in Poland, made possible through a strategic collaboration with testDNA Sp. z o. o. Sp. K.

August 22, 2023
·
6 min read
Business

Berlin Heals Holding AG welcomes Dr. Felix Baader and Roland Diggelmann as new board members Final phase of ongoing CE study started

Berlin Heals Holding AG, a Swiss medical technology company, is delighted to announce the appointments of Dr. Felix Baader and Roland Diggelmann as new members of the Board of Directors.

August 22, 2023
·
2 min read
Actimed Therapeutics secures additional £4.75m funding in Series A extension round, almost doubling Series A proceeds

Actimed Therapeutics Ltd announces it has raised a further £4.75m in an extension to its recent Series A financing round which was completed in June this year.

August 22, 2023
·
4 min read
‘Positive results from PK study with cobitolimod’ selected as one of the best abstracts for poster presentation at UEGW: InDex Pharmaceuticals

InDex Pharmaceuticals Holding AB announced that the positive results from the pharmacokinetic study with cobitolimod in patients with moderate to severe ulcerative colitis will be presented at one of the leading gastroenterology conferences, the United European Gastroenterology Week.

August 22, 2023
·
3 min read
BerGenBio announces clinical data presentations highlighting the activity of its selective AXL inhibitor bemcentinib in Non-Small Cell Lung Cancer

BerGenBio ASA announced that additional clinical data of bemcentinib in combination with chemotherapy and with immunotherapy in Non-Small Cell Lung Cancer have been recently published and accepted for presentation at two upcoming international oncology conferences.

August 22, 2023
·
2 min read
Affimed Announces Publication in the Journal mAbs on Leveraging FcRn-pH-HPLC as a Method to Select Bispecific Antibodies with Optimal Developability

Affimed N.V. announced the publication of a manuscript that demonstrates how the FcRn-pH-HPLC technology can be leveraged to predict PK properties of various ICE® formats built on the ROCK® platform.

August 22, 2023
·
5 min read
Drug Development

Kintor Pharma Announces Completion of Patient Enrollment in Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China

Kintor Pharmaceutical Limited announced that the company has completed the enrollment of 180 patients for the Phase II clinical trial of its in-house developed first-in-class proteolysis targeting chimera compound GT20029 in China for the treatment of male androgenetic alopecia.

August 22, 2023
·
2 min read
BioForest

BaroPace, Inc. Announced First Patient Enrolled in Non-Pharmacologic Hypertension and Heart Failure Treatment Trial

BaroPace Inc. announced that the first patient has been enrolled in the Company’s First-in-Human clinical trial, RelieveHFpEF-II.

August 22, 2023
·
2 min read